Guardant Health Inc
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
GH$155.35-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
(in thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net loss | $(479,449) | $(654,588) | $(384,770) |
| Other comprehensive income (loss), net of tax impact: | |||
| Unrealized gain (loss) on available-for-sale securities | 16,758 | (13,158) | (5,769) |
| Foreign currency translation adjustments | (911) | (1,600) | (1,692) |
| Other comprehensive income (loss) | 15,847 | (14,758) | (7,461) |
| Comprehensive loss | $(463,602) | $(669,346) | $(392,231) |
| Comprehensive loss attributable to redeemable noncontrolling interest | — | — | (20,900) |
| Comprehensive loss attributable to Guardant Health, Inc. common stockholders | $(463,602) | $(669,346) | $(413,131) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.